Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Upper respiratory tract infection
ADR ID BADD_A04424
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.13      Upper respiratory tract infections
11.01.13.009      Upper respiratory tract infection
22      Respiratory, thoracic and mediastinal disorders
22.07      Respiratory tract infections
22.07.03      Upper respiratory tract infections NEC
22.07.03.011      Upper respiratory tract infection
Description Not Available
MedDRA Code 10046306
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Acute upper respiratory infection of multiple or unspecified sites | Acute upper respiratory infections of multiple or unspecified sites | Acute upper respiratory infections of other multiple sites | Acute upper respiratory infections of unspecified site | Infection upper respiratory | Upper resp tract infection | Upper respiratory infection | Upper respiratory tract infection | Upper respiratory tract infection NOS | URI | URTI | URTI (upper respiratory tract infection) | Acute upper respiratory tract infection | Ear, nose and throat infection
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Cytochrome P450 2D6P10635T57392
Cytochrome P450 3A4P08684T37848
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02389Ziprasidone hydrochloride--
BADD_D02392Zoledronic acid--
BADD_D02394Zolpidem--
BADD_D02395Zolpidem tartrate--
BADD_D02419Rosiglitazone--
BADD_D02433Salbutamol0.000039%
BADD_D02443Tiotropium0.000730%
BADD_D02452Icatibant-
BADD_D02458Glycine betaine0.097284%
BADD_D02464Fingolimod0.080480%
BADD_D02468Cannabidiol--
BADD_D02470Nintedanib--
BADD_D02473Sodium chloride0.000604%
BADD_D02487Baricitinib0.001158%
BADD_D02492Deflazacort0.000579%
BADD_D02498Abemaciclib--
BADD_D02510Rucaparib0.003197%
BADD_D02511Siponimod0.001158%
The 19th Page    First    Pre   19    Total 19 Pages